Skip to main navigation Skip to search Skip to main content

A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression

  • Jiabo Li
  • , Ling Kai Shih
  • , Steven M. Markwell
  • , Cheryl L. Olson
  • , David P. Sullivan
  • , Constadina Arvanitis
  • , James L. Ross
  • , Nicolas G. Lam
  • , Hannah Nuszen
  • , Dolores Hambardzumyan
  • , Oren J. Becher
  • , Daniel J. Brat

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

All glioblastoma (GBM) molecular subsets share the common trait of accelerated progression following necrosis, which cannot be adequately explained by cellular proliferation arising from accumulated genetic alterations. Counter to dogma that “cancer outgrows its blood supply,” we suggest that development of necrosis is not merely a consequence of aggressive neoplastic growth but could be a contributing force causing tumor microenvironment (TME) restructuring and biologic progression. Mechanisms related to necrotic contributions are poorly understood due to a lack of methods to study necrosis as a primary variable. To reveal spatiotemporal changes related to necrosis directly, we developed a mouse model and methodology designed to induce clinically relevant thrombotic vaso-occlusion within GBMs in an immunocompetent RCAS/tv-a mouse model to study TME restructuring by intravital microscopy and demonstrate its impact on glioma progression. Diffuse high-grade gliomas are generated by introducing RCAS-PDGFB-RFP and RCAS-Cre in a Nestin/tv-a; TP53fl/fl PTENfl/fl background mouse. We then photoactivate Rose Bengal in specific, targeted blood vessels within the glioma to induce thrombosis, hypoxia, and necrosis. Following induced necrosis, GBMs undergo rapid TME restructuring and radial expansion, with immunosuppressive bone marrow–derived, tumor-associated macrophages (TAMs) and glioma stem cells (GSCs) increasing dramatically in the perinecrotic niche. Collectively, this model introduces necrosis as the primary variable and captures glioma TME and growth dynamics in a manner that will facilitate therapeutic development to antagonize these mechanisms of progression.

Original languageEnglish
Article numbere2416024122
JournalProceedings of the National Academy of Sciences of the United States of America
Volume122
Issue number7
DOIs
StatePublished - 19 Feb 2025
Externally publishedYes

Keywords

  • glioblastoma
  • glioma stem cell
  • mouse model
  • necrosis
  • tumor-associated macrophage

Fingerprint

Dive into the research topics of 'A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression'. Together they form a unique fingerprint.

Cite this